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Abstract
Background: Rhei Rhizoma has been widely used as a traditional herbal medicine to treat various
inflammatory diseases. The present study was conducted to evaluate its anti-inflammatory activity against
experimental reflux-induced esophagitis (RE) in SD rats.
Methods: Rhei Rhizoma was administered at 125 or 250 mg/kg body weight per day for 7 days prior to the
induction of reflux esophagitis, and its effect was compared with RE control and normal rats.
Results: Rhei Rhizoma administration markedly ameliorated mucosal damage on histological evaluation. The
elevated reactive oxygen species in the esophageal tissue of RE control rats decreased with the
administration of Rhei Rhizoma. RE control rats exhibited the down-regulation of antioxidant-related proteins,
such as nuclear factor-erythroid 2-related factor 2 (Nrf2) and heme oxygenase-1 (HO-1) expression levels, in
the presence of esophagitis; however, the levels with Rhei Rhizoma treatment were significantly higher than
those in RE control rats. Moreover, RE control rats exhibited the up-regulation of protein expressions related
to oxidative stress in the presence of esophagitis, but Rhei Rhizoma administration significantly reduced the
expression of inflammatory proteins through mitogen-activated protein kinase (MAPK)-related signaling
pathways. The protein expressions of inflammatory mediators and cytokines by nuclear factor-kappa B (NF-κB)
activation were modulated through blocking the phosphorylation of inhibitor of nuclear factor kappa B (IκB)α.
Conclusion: Our findings support the therapeutic evidence for Rhei Rhizoma ameliorating the development
of esophagitis via regulating inflammation through the activation of the antioxidant pathway.
Keywords: Rhei Rhizoma, Reflux esophagitis, Gastroesophageal reflux disease, Oxidative stress, Inflammation,
Antioxidation
Background
Gastroesophageal reflux disease (GERD), including re-
flux esophagitis, is mainly caused by excessive exposure
to the gastric contents, namely acid, pepsin, trypsin, and
bile acids, as well as the functional and structural abnor-
mality of the esophagitis [1]. The main symptoms of
GERD are acid regurgitation and heartburn [2]. GERD
prevalence estimates were 18.1–27.8 % in North
America, 8.8–25.9 % in Europe, 2.5–7.8 % in East Asia,
8.7–33.1 % in the Middle East, 11.6 % in Australia, and
23.0 % in South America [3]. The existing therapeutic
strategy for GERD is primarily acid suppression such as
using antacids, H2-receptor antagonists, and proton
pump inhibitors (PPIs) [4]. Despite their well-known ef-
ficacy, a number of patients have experienced relapse,
incomplete mucosal healing, and the development of se-
vere complications like Barrett’s esophagus. Also, these
agents have adverse effects associated with long-term
use [5–7].
Recent studies reported that oxidative stress is more
important than acid in the pathogenesis of reflux
* Correspondence: ptman123@daum.net; ddede@dhu.ac.kr
†Equal contributors
3Department of Herbology, College of Korean Medicine, DaeguHaany
University, 136, Shinchendong-ro, Suseong-gu, Deagu 42158, Republic of
Korea
Full list of author information is available at the end of the article
© 2016 Kwon et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Kwon et al. BMC Complementary and Alternative Medicine  (2016) 16:7 
DOI 10.1186/s12906-015-0974-z
esophagitis in rats [8–10]. Oxidative stress could lead to
leukocyte activation, the production of ROS, and in-
crease of tissue damage [11]. In studies carried out on
animal models of esophagitis as well as those on human
esophageal tissue, ROS were found to be responsible for
esophageal tissue damage. ROS, such as superoxide an-
ions (O2
−), hydrogen peroxide (H2O2), and hydroxyl radi-
cals (∙OH), are released excessively in inflammatory
gastroesophageal tissues. Overproduction of ROS can
contribute to the immediate development of inflamma-
tory processes. Administration of antioxidants, free rad-
ical scavengers, has been reported to prevent esophageal
mucosal damage by blocking free radicals [12].
Rhei Rhizoma (rhubarb, Dahuang in Chinese) is one of
the traditional herbal medicine widely used in Chinese,
Korean, and Japanese pharmacopoeias. It is known to
exert several biological effects, which involve purgative,
antipyretic, anti-inflammatory, anti-angiogenic, and anti-
neoplastic activities [13–15]. The previous study re-
ported that the administration of rhubarb modulated
acute inflammatory response in patients with gastric
cancer [16]. Furthermore, we previously reported the in-
crease in free radical scavenging activities of Rhei Rhi-
zoma and Glycyrrhiza Rhizoma combined extract (RGE)
in the inflammation induced ROS [17]. Moreover, Wen-
Pi-Tan including Rhei Rhizoma exerted potent anti–oxi-
dant effect and anti-lipid peroxidation on oxidative
stress and Rhei Rhizoma also promoted incision wound
healing and protective effects on gastric ulcer in rats [18,
19]. Primary constituents of Rhei Rhizoma are anthra-
noids, including sennoside A. Oral intake of Sennoside
A is transformed into rhein by bacterial enzymes in the
large intestine [20]. Rhein, one of the important active
components of Rhei Rhizoma, showed a protective effect
against oxidative stress-related endothelial cell injury
[21]. The results demonstrated that the antioxidative ac-
tivity of Rhei Rhizoma can be used therapeutically for
inflammation-based GERD including reflux esophagitis.
Therefore, we investigated the effects of Rhei Rhizoma
on rats with reflux esophagitis to examine its preventive
effect against oxidative stress-related inflammation.
Methods
Materials
Protease inhibitor mixture solution and ethylenedi-
aminetetraacetic acid (EDTA) were purchased from
Wako Pure Chemical Industries, Ltd. (Osaka, Japan).
Phenylmethylsulfonyl fluoride (PMSF) was purchased
from Sigma Aldrich Co., Ltd. (St. Louis, MO, USA).
2′,7’-Dichlorofluorescein diacetate (DCFH-DA) was ob-
tained from Molecular Probes (Eugene, OR, USA). ECL
Western Blotting Detection Reagents and pure nitrocel-
lulose membranes were supplied by GE Healthcare (Pis-
cataway, NJ, USA). Rabbit polyclonal antibodies against
Nrf2, HO-1, p-p38, p-ERK1/2, NF-κBp65, and mouse
monoclonal antibodies against, and p-IκBα, COX-2,
iNOS, TNF-α, IL-6, histone, and β-actin were purchased
from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA,
USA). Rabbit anti-goat, goat anti-rabbit, and goat anti-
mouse immunoglobulin G (IgG) horseradish peroxidase
(HRP)-conjugated secondary antibodies were acquired
from Santa Cruz Biotechnology, Inc. All other chemicals
and reagents were purchased from Sigma Aldrich Co.,
Ltd. (St. Louis, MO, USA).
Plant materials
Rhei Rhizoma was purchased from Ominherb Co.
(Youngcheon, Korea). A voucher herbarium specimen
has been deposited at the Herbarium of DaeguHaany
University and was identified by Prof. S.S. Roh, the herb-
arium leader of this university. Dried slices of Rhei Rhi-
zoma (100 g) were extracted with distilled water
(1,000 mL) at room temperature for 2 h, and the solvent
was evaporated in vacuo to give an extract with a yield
of 23.1 %, by weight, of the original Rhei Rhizoma.
Analysis of Rhei rhizoma by HPLC chromatogram
The water extract of Rhei rhizoma (1 mg) was dissolved
in 1 mL of 50 % methanol with multi-vortexing. We
injected 50 μL of the sample into a reverse-phase HPLC
using a ZORBAX Eclipse XDB-C18, Analytical 4.6 X
150 mm, 5-μm, with a column temperature of 25 °C.
Mobile phase component A =methanol and B = water
(10 mM 1-hexanesulfonic acid sodium). The gradient
conditions were as follows: 15 % A; 0 min, 50 % A;
15 min, 30 % A, 30 min. The flow rate was 2.0 mL/min.
The UV absorbance from 254 nm was monitored using
an Agilent 1200 series with an 2998 Photodiode Array
Detector from Waters Co. (Manchester, UK). All peaks
were assigned by carrying out co-injection tests with au-
thentic samples and comparing them with the UV spec-
tral data. Sennoside A was detected from Rhei rhizoma.
The measurement was repeated three times. Representa-
tive HPLC result is illustrated in Fig. 1.
Experimental animals and treatment
Six-week-old male Sprague–Dawley rats (B.W. 180 g -
200 g) were purchased from Samtako (Osan, Korea).
Rats were maintained under a 12-h light/dark cycle,
housed at a controlled temperature (24 ± 2 °C) and hu-
midity (about 60 %). After adaptation (1 week), the rats
(n = 24) were divided into four groups, avoiding any
inter-group differences in body weight. The normal and
vehicle-treated reflux esophagitis groups were given
water, while the other groups were orally administered
Rhei Rhizoma extract at a dose 125 or 250 mg/kg body
weight daily using a stomach tube for 7 consective days
(n = 6 in each group). The oral doses were determined in
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a preliminary study, which demonstrated biological ac-
tivity without toxicity [22]. At the end of the administra-
tion period, the rats were fasted for 18 h prior to
surgical procedures and kept in raised mesh-bottom
cages to prevent coprophagy. And then rats were anaes-
thetized with an injection of Zoletil at 0.75 mg/kg
(Virbac S.A. France). A midline laparotomy was per-
formed to expose the stomach, and then both the pyl-
orus and transitional junction between the forestomach
and corpus were first exposed, and later ligated with a
2–0 silk thread but without a plyoric ring, contrary to
the procedure originally proposed by Omura et al. [23].
The vagus nerves were left intact. At 6 h after the sur-
gery, all rats were sacrificed. The entire esophagus was
removed immediately and examined for gross mucosal
injury. The esophageal tissue was immediately frozen in
liquid nitrogen and blood samples were collected by
vena cava puncture from anesthetized rats. Subse-
quently, the esophagus and serum were kept at −80 °C
until analysis.
Esophageal lesion ratio
The rat esophagus was cut with scissors in a longitu-
dinal direction from the gastroesophageal junction to
the pharynx after sacrifice. The inner mucous was
washed away with 0.9 % NaCl and the remaining tis-
sue was laid out on paper. Thereafter, the dissected
esophagus was photographed with an optical digital
camera (Sony, Tokyo, Japan) and analyzed using the
i-solution lite software program. The gross mucosal
damage ratio was calculated as follows: the gross mu-
cosal damage ratio (%) = [width of area with esopha-
geal mucosal damage (mm2)/width of total area of

















Fig. 1 HPLC profile of Rhei Rhizoma at 254 nm wavelength. a chemical structure. b Sennoside A
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Histological examination in the esophagus
For microscopic evaluation, the opened esophagus was
cut to isolate the middle segment. This segment was
fixed in 10 % neutral-buffered formalin and, after em-
bedding in paraffin, cut into 2-μm sections and stained
using hematoxylin and eosin (H/E). The stained slices
were subsequently observed under an optical microscope
and analyzed using the i-Solution Lite software program
(Innerview Co. Korea).
Measurement of gastric pH
After sacrifice, the stomach of each rat was washed with
1 mL of 0.9 % NaCl (pH 7.4) using a 1,000-μL micropip-
ette. The pH of the collected gastric juices were mea-
sured using a pH meter (EcoMet, iSTEK Co., Seoul,
Korea).
Measurement of ROS and TBARS levels in the esophagus
Esophageal ROS levels were measured employing the
method of Ali et al. [24]. Esophageal tissues were ho-
mogenized on ice with 1 mM EDTA-50 mM sodium
phosphate buffer (pH 7.4), and then 25 mM DCFH-DA
was added to homogenates. After incubation for 30 min,
the changes in fluorescence values were determined at
an excitation wavelength of 486 nm and emission wave-
length of 530 nm. The TBARS level was estimated ac-
cording to the method of Mihara and Uchiyama [25].
Preparation of nuclear and post-nuclear fractions
Nuclear protein extraction was performed according to
the method of Komatsu [26]. In brief, esophageal tissues
were homogenized with ice-cold lysis buffer containing
5 mM Tris–HCl (pH 7.5), 2 mM MgCl2, 15 mM CaCl2,
and 1.5 M sucrose, and then 0.1 M dithiothreitol (DTT)
and protease inhibitor mixture solution were added.
After centrifugation (10,500 x g for 20 min at 4 °C), the
pellet was suspended with extraction buffer containing
20 mM 2-[4-(2-hydroxyethyl)-1-piperazyl] ethanesulfo-
nic acid (pH 7.9), 1.5 mM MgCl2, 0.42 M NaCl, 0.2 mM
EDTA, and 25 % (v/v) glycerol, and then 0.1 M DTT and
protease inhibitor mixture solution were added. The
mixture was placed on ice for 30 min, and then the nu-
clear fraction was prepared by centrifugation at 20,500 ×
g for 5 min at 4 °C. The post-nuclear fraction was ex-
tracted from the esophagus of each rat, as described
below. In brief, esophageal tissue was homogenized with
ice-cold lysis buffer (pH 7.4) containing 137 mM NaCl,
20 mM Tris–HCl, 1 % Tween 20, 10 % glycerol, 1 mM
PMSF, and protease inhibitor mixture solution. The
homogenate was then centrifuged at 2,000 × g for
10 min at 4 °C. The protein concentration in each frac-
tion was determined using a Bio-Rad protein kit (Bio-
Rad Laboratories, Hercules, CA, USA).
Immunoblotting analyses
For the estimation of Nrf2, NF-κBp65, and histone,
10 μg of protein from each nuclear fraction was electro-
phoresed through 8–10 % sodium dodecylsulfate poly-
acrylamide gel (SDS-PAGE). Separated proteins were
transferred to a nitrocellulose membrane, blocked with
5 % (w/v) skim milk solution for 1 h, and then incubated
with primary antibodies to Nrf2, NF-κBp65, and histone,
respectively, overnight at 4 °C. After the blots were
washed, they were incubated with anti-rabbit or anti-
mouse IgG HRP-conjugated secondary antibody for
1.5 h at room temperature. Also, 10–15 μg of protein of
each post-nuclear fraction of HO-1, p-p38, p-ERK1/2,
IκBα, COX-2, iNOS, TNF-α, IL-6, and β-actin was elec-
trophoresed through 8–15 % SDS-PAGE. Each antigen-
antibody complex was visualized using ECL Western
Blotting Detection Reagents and detected by chemilu-
minescence with Sensi-Q 2000 Chemidoc (Lugen Sci
Co., Ltd., Gyeonggi-do, Korea). Band densities were
measured using ATTO Densitograph Software (ATTO
Corporation, Tokyo, Japan) and quantified as the ratio to
histone or β-actin. The protein levels of groups are
expressed relative to those of normal rats (represented
as 1).
Ethical approval
Ethical approval for the study was granted by the Uni-
versity of Daegu Haany Ethical Committee on the 06/
02/2015 with certificate number DHU2015-009.
Statistical analysis
The data are expressed as the mean ± standard deviation.
Significance was assessed by one-way analysis of variance
(ANOVA) followed by Dunnett’s multiple comparison test
(SPSS 11.5.1 for Windows, 2002, SPSS Inc., Chicago, IL,
USA). Values of P < 0.05 were considered significant.
Results
Gross mucosal damage and histological analysis in the
esophagus
Figure 2 shows the results on morphological examin-
ation of the esophagus. Morphological changes such as
hyperemia and multiple erosions were observed in reflux
esophagitis rats. Damage in normal rats was not
apparent. The oral administration of Rhei Rhizoma led
to a marked decrease of gross mucosal damage (p <
0.05). In addition, esophageal tissue stained with H&E
revealed no microscopic mucosal changes in normal rat
(Fig. 3a). The normal esophagus exhibited a thin epithe-
lial layer with squamous cells and inflammatory cells
were not observed in the submucosal layers. By contrast,
6 h subsequent to the induction of RE, RE control rats
developed large coalesced longitudinal ulcers in the
esophagus sections. Mucosal damage and hyperemia of
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the epithelial layers and edema and hemorrhage in the
mucosa and submucosa were observed in the RE control
rats (Fig. 3b). However, the administration of Rhei Rhi-
zoma 125 or 250 mg/kg showed less severe pathological
changes (Fig. 3c and d, respectively).
Gastric pH
The reflux-induced esophagitis rats displayed a marked
decrease in the gastric pH, as shown in Fig. 4. However,







































Fig. 2 Effects of Rhei Rhizoma on gross esophageal damage. a Morphological examination of the esophagus in each group. b Gross mucosal
damage ratio. N, normal rats; Veh, RE control rats; RR125, Rhei Rhizoma 125 mg/kg-treated reflux esophagitis rats; RR250, Rhei Rhizoma 250 mg/
kg mg/kg-treated reflux esophagitis rats. Data are mean ± SD Significance: *P < 0.001 versus RE control rat values
a b c d
Fig. 3 Effect of Rhei Rhizoma on esophageal histology. (original magnification 200×) a, normal rats esophagus tissue stained with H&E; b, RE
control rats esophagus tissue stained with H&E; c, Rhei Rhizoma 125 mg/kg-treated reflux esophagitis rats esophagus tissue stained with H&E; d,
Rhei Rhizoma 250 mg/kg mg/kg-treated reflux esophagitis rats esophagus tissue stained with H&E
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Biomarkers associated with oxidative stress in the
esophagus
As shown in Table 1, the levels of oxidative stress-
related biomarkers, ROS and TBARS, in the esopha-
gus of RE control rats were markedly higher than
those of normal rats (p < 0.01), whereas, by the ad-
ministration of Rhei Rhizoma at a dose of 250 mg/kg
to esophagitis rats, the elevated levels were markedly
decreased nearly to the levels of normal rats (p <
0.01). The 125 mg/kg Rhei Rhizoma-treated rats also
showed a significant decrease (ROS; p < 0.05, TBARS;
p < 0.01).
Oxidative stress-related protein expressions in the
esophagus
Figure 5 showed that esophageal expressions of Nrf2
and HO-1 in RE control rats were significantly decreased
compared with those of normal rats (p < 0.001). How-
ever, Rhei Rhizoma administration adversely regulated
the nuclear Nrf2 and cytosolic HO-1 expressions in the
esophagus of reflux-induced esophagitis rats. Overall,
the ameliorative effects of Rhei Rhizoma 250 mg/kg
treatment were superior to those when 125 mg/kg treat-
ment. Especially, our data showed that Rhei Rhizoma
stimulated not SOD-1 and catalase but Nrf2 pathway.
(Additional file 1: Figure S1)
MAPK-related protein expressions in the esophagus
MAPK-related protein expressions were augmented in
the esophagus of RE control rats compared to the nor-
mal rats (p < 0.001), but the oral administration of Rhei
Rhizoma significantly decreased the expressions of p-
p38 and p-ERK1/2 in a dose-dependent manner, as
shown in Fig. 6.
Inflammation-related protein expressions in the
esophagus
As shown in Fig. 7, protein levels such as p-IκBα (p <
0.001) and NF-κBp65 (p < 0.01) were enhanced in the
esophagus of RE control rats, whereas these elevated
levels were significantly reduced in Rhei Rhizoma-
treated RE rats dose-dependently. Especially, the NF-
κBp65 level was lowered nearly to that of normal rats by
250 mg/kg Rhei Rhizoma treatment (p < 0.01). Moreover,
the expression levels of COX-2, iNOS, TNF-α were also
enhanced in the esophagus of RE control rats in a dose-
dependent manner by Rhei Rhizoma treatment (Fig. 8).
Rhei Rhizoma 250 mg/kg treatment effectively sup-
pressed more than 125 mg/kg treatment. However, IL-6
showed a tendency to decrease without significance.
Discussion
In present study, we identified a novel function of Rhei
Rhizoma as a effective therapeutic modulator for Reflux
Esophagiti (RE) and elucidated the tagrget mechanisms.
The administration of Rhei Rhizoma significantly re-
duced esophageal mucosal damage and and the levels of
RE related pathogenic inflammatory mediators and cyto-
kines. RE, commonly referred as GERD, is a chronic and
relapsing esophageal pathology, having a significant im-
pact on the quality of life and healthcare costs [27].
Gastroesophageal reflux has also been implicated in the
development of esophageal stricture and Barret’s esopha-
gus, and was associated with a greater risk of the devel-
opment of esophageal cancer. The etiology of reflux
esophagitis is complex and multifactorial rather than a























Fig. 4 Gastric pH. N, normal rats; Veh, RE control rats; RR125,
Rhei Rhizoma 125 mg/kg-treated reflux esophagitis rats; RR250,
Rhei Rhizoma 250 mg/kg mg/kg-treated reflux esophagitis rats.
Data are mean ± SD. Significance: *P < 0.001 versus RE control
rat values








2748 ± 659** 7.5 ± 0.4**
RE rats
Veh 29600 ± 8517 14.0 ± 0.8
RR125 9550 ± 5129* 8.6 ± 0.1**
RR250 3408 ± 661** 6.3 ± 0.4**
N, normal rats; Veh, RE control rats; RR125, Rhei Rhizoma 125 mg/kg body
weight-administrated and RE rats; RR250, Rhei Rhizoma 250 mg/kg body
weight-administrated and RE rats. Data are the mean ± SD
Significance: *p < 0.01, **p < 0.001 vs. RE control rat values. n = 6 in each group
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mucosal to physiological reflux, reduced mucosal
defense mechanisms, and gastric motility disturbances
[28]. It is generally known that reflux of the gastric con-
tents causes inflammation, ulceration, and destruction of
the normal squamous epithelium of the esophagus [8].
In recent studies, it was shown that mucosal damage in
reflux esophagitis is mediated primarily by oxygen-
derived free radicals. The administration of various free
radical scavengers has been reported to prevent esopha-
geal mucosal damage [29].
The Rhei Rhizoma has richly sennoside A which was
included in dianthrone glycosides. Sennoside A is trans-
formed into an bioactive metabolite, rheinanthrone, and
then rhein by intestinal bacteria. Particularly Sennoside
A exerts the gastroprotective activity via the up-
regulation of prostaglandin E2 and the Inhibition of
H(+)/K(+)-ATPase [30]. Rhein induces apoptosis of gas-
tric cancer cells through an intrinsic mitochondrial path-
way [31]. The derivatives of Sennoside A has been

























































Fig. 5 Antioxidant enzyme-related protein expressions in the esophagus. a Nrf2 protein expressions. b HO-1 protein expressions in each group.
N, normal rats; Veh, RE control rats; RR125, Rhei Rhizoma 125 mg/kg-treated reflux esophagitis rats; RR250, Rhei Rhizoma 250 mg/kg mg/kg-



































Fig. 6 MAPK-related protein expressions in the esophagus. a p-p38 protein expressions. b p-ERK1/2 protein expressions in each group. N, normal
rats; Veh, RE control rats; RR125, Rhei Rhizoma 125 mg/kg-treated reflux esophagitis rats; RR250, Rhei Rhizoma 250 mg/kg mg/kg-treated reflux
esophagitis rats. Data are mean ± SD. (n = 6) Significance: *P < 0.05, **P < 0.01, ***P < 0.001 versus RE control rat values
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H2O2, light, and γ-radiation induced oxidative stress via
the suppression of ROS production and scavenging of
free radicals [32, 33]. However, the mechanisms under-
lying the effects of Rhei Rhizoma have yet to be investi-
gated in an experimental model of reflux esophagitis.
Therefore, the present study was conducted using an ex-
perimental reflux esophagitis model.
The general pathophysiology of gastric disorders is an
imbalance between digestive and protective factors in
the stomach, such as acid-pepsin secretion, the mucosal
barrier, mucus secretion, blood flow, cellular regener-
ation, prostaglandins, and epidermal growth factors. The
pylorus ligation model shows increases in the gastric
volume, acid-pepsin concentration, and acid-pepsin out-
put [34]. These stresses have been reported to induce
gastric ulcers and increase free radical generation aside
from acid-pepsin factors. In this study, RE control rats
showed a markedly decreased gastric pH, similarly to an-
other study, and elevated oxidative stress-related factors.
However, the administration of Rhei Rhizoma did not
affect regulation of the gastric pH. Nevertheless, the
esophageal macroscopic and histological lesions were re-
duced markedly through the different mechanism with-
out regulating the gastric pH [35].
ROS were reported to play a role in the pathogenesis of
several gastrointestinal diseases such as inflammatory
bowel disease and peptic ulcer [9]. ROS generated in the
process of reflux esophagitis were found to be responsible
for esophageal tissue damage [36], and this finding was
further supported by studies showing that tissue damage
could be prevented by the antioxidant activity. ROS in-
duces alterations in the Nrf2 complex, and its gene tran-
scription, such as that of HO-1, is enhanced. Nrf2, which
is a redox-sensitive transcription factor, plays a vital role
in protection against oxidant-induced cellular injury.
Therefore, the Nrf2/HO-1 pathway could be a biomarker
of oxidative stress and an adaptive response under patho-
logical conditions [37]. In the present study, esophageal
reflux induced esophageal tissue damage triggered by an
ROS-sensitive pathway, and oxidative stress was reduced
significantly by the administration of Rhei Rhizoma.
Moreover, reflux esophagitis rats showed decreased
expressions of Nrf2 and HO-1 in esophageal tissues
compared with normal rats; however, Rhei Rhizoma
administration effectively alleviated oxidative stress and
resulted in the up-regulation of Nrf2 and HO-1.
Meanwhile, Rhei Rhizoma showed a tendency to increase
the SOD and catalase levels without significance. (see
Additional file 1: Figure S1).
The accumulation of ROS in gastric epithelium has
been linked to gastric carcinogenesis (as well as
inflammation). ROS overexpression activates MAPK
including p38 and ERK1/2. The MAPK cascades on
p38 and ERK are proving to play major roles in the
regulation of intracellular metabolism and gene ex-
pression in many areas, including disease, apoptosis,
and cellular responses to external stresses. Further-





































Fig. 7 p-IκBα and NF-κBp65 protein expressions in the esophagus. a p-IκBα protein expressions. b NF-κBp65 protein expressions in each group.
N, normal rats; Veh, RE control rats; RR125, Rhei Rhizoma 125 mg/kg-treated reflux esophagitis rats; RR250, Rhei Rhizoma 250 mg/kg mg/kg-
treated reflux esophagitis rats. Data are mean ± SD. (n = 6) Significance: *P < 0.05, **P < 0.01, ***P < 0.001 versus RE control rat values
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leads to NF-κB translocation. The NF-κB element is
believed to be the main regulator of the inducible ex-
pression of inflammatory genes. Activated ERK1/2
induces the dissociaton of IκBα to NF-κB, allowing
the nuclear translocation and DNA-binding of NF-κB,
and p38 induces the expression of p65 and p50 [38,
39]. In this study, increased expressions of p-ERK1/2
and p-p38 were observed in esophageal tissues of RE
control rats, and were decreased by the administra-
tion of Rhei Rhizoma. The results of the present
study show that Rhei Rhizoma blocked the phosphor-
ylation of IκBα and prevented the nuclear transloca-
tion NF-κB in esophageal tissue. Namely, the
administration of Rhei Rhizoma markedly suppressed
NF-κB activation through the direct inhibition of
phosphorylation of IκBα
Excessive activation of NF-κB can lead to serious in-
flammatory diseases and cancers. NF-κB promotes the
transcription of target genes such as TNF-α and IL-6,
and regulates the expression of inducible enzymes such
as COX-2 and iNOS. When monocytes and macro-
phages are exposed to inflammatory stimuli, they secrete
cytokines such as TNF-α and IL-6. TNF-α induces a
number of physiological effects, including septic shock,
inflammation, and cytotoxicity [40]. IL-6 is a pleiotropic
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Fig. 8 COX-2, iNOS, TNF-α, and IL-6 protein expressions in the esophagus. a COX-2 protein expressions. b iNOS protein expressions c TNF-α pro-
tein expressions d IL-6 protein expressions in each group. N, normal rats; Veh, RE control rats; RR125, Rhei Rhizoma 125 mg/kg-treated reflux
esophagitis rats; RR250, Rhei Rhizoma 250 mg/kg mg/kg-treated reflux esophagitis rats. Data are mean ± SD. (n = 6) Significance: *P < 0.05,
**P < 0.01, ***P < 0.001 versus RE control rat values
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inflammatory functions that affect processes ranging
from immunity to tissue repair and metabolism. It pro-
motes the differentiation of B cells into plasma cells, ac-
tivates cytotoxic T cells, and regulates bone homeostasis
[41]. The role of COX-2 was augmented under inflam-
matory conditions, such as reflux esophagitis and Bar-
rett’s esophagus [42], and iNOS, which generates NO, is
an important mediator of reflux-induced cell signaling in
esophageal cells [43]. The up-regulation of iNOS expres-
sion results in the overproduction of NO. NO reacts
with O2
− and forms ONOO−. ONOO− can directly cause
DNA damage and participate in inflammation-related
carcinogenesis [44]. In the present study, Rhei Rhizoma
treatment of the reflux esophagitis model significantly
decreased esophageal protein up-regulation of NF-κB-
related inflammatory mediators (COX-2 and iNOS) (Fig. 8).
In addition, the elevated protein expressions of TNF-α and
IL-6 were significantly down-regulated by the administra-
tion of Rhei Rhizoma (Fig. 8).
A recent study showed that ROS are one of the most
important factors in the pathogenesis of esophageal
mucosal injury mediated by oxidative stress in an ex-
perimental model of reflux esophagitis. In the present
study, the administration of Rhei Rhizoma reduced the
oxidative stress biomarker without modifying the gas-
tric pH. These results revealed an antioxidant effect
through Nrf2-mediated HO-1 induction. Furthermore,
the anti-inflammatory effect of Rhei Rhizoma suggested
that the inactivation of NF-κB by blocking MAPK such
as through p38 and ERK1/2 signaling pathways leads to
an inhibition of the release of proinflammatory cyto-
kines and mediators. That is, Rhei Rhizoma ameliorated
inflammation with esophageal mucosal injury caused by
experimental reflux esophagitis in rats, as shown in
Fig. 9.
Conclusions
The administration of Rhei Rhizoma effectively amelio-
rates inflammatory damage in the esophageal mucosa
through activation of the Nrf2/HO-1 antioxidant pathway.
Additional file
Additional file 1: Figure S1. Antioxidant enzyme-related protein
expressions in the esophagus. a SOD-1 protein expressions. b catalase
protein expressions in each group. N, normal rats; Veh, RE control rats;
RR125, Rhei Rhizoma 125 mg/kg-treated reflux esophagitis rats; RR250, Rhei
Rhizoma 250 mg/kg treated reflux esophagitis rats. Data are mean ± SD
(n = 6). The esophageal expressions of SOD-1 and catalase in RE control
rats showed a tendency to decrease without significance compared
with those of normal rats. The decreased SOD-1 and catalase levels
slightly increased by the treatment of Rhei Rhizoma. However, it did not
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Fig. 9 Possible mechanism of Rhei Rhizoma in the esophagus of reflux-induced esophagitis rats
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